Open AccessLBMON178 2nd Year Outcomes Of The Open-label Extension Of Chiasma Optimal, A Phase 3 Study Of Oral Octreotide Capsules In Acromegaly
Author(s) -
Susan L. Samson,
Lisa B. Nachtigall,
Maria Fleseriu,
Mark E. Molitch,
Andrea Giustina,
Asi Haviv,
Nienke R. Biermasz,
Laurence Kennedy,
Mojca Jensterle,
Patrick Manning,
Атанаска Еленкова,
Шломо Мелмед,
Christian J. Strasburger
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.984
Subject(s) - acromegaly , medicine , octreotide , placebo , somatostatin , chiasma , clinical endpoint , growth hormone , gastroenterology , clinical trial , hormone , biology , chromosome , gene , biochemistry , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom